Tofte, Nete http://orcid.org/0000-0002-5331-9168
Suvitaival, Tommi
Ahonen, Linda http://orcid.org/0000-0001-7704-3912
Winther, Signe A.
Theilade, Simone
Frimodt-Møller, Marie
Ahluwalia, Tarunveer S.
Rossing, Peter http://orcid.org/0000-0002-1531-4294
Funding for this research was provided by:
Novo Nordisk Fonden (NNF14OC0013659)
Article History
Received: 13 June 2019
Accepted: 24 October 2019
First Online: 8 November 2019
Competing interests
: The authors declare no competing interests that could be perceived as prejudicing the impartiality of the research reported. Outside this study, P.R. reports personal shares in Novo Nordisk, having given lectures for Mundi Pharma, Eli Lilly and Boehringer Ingelheim, being in the advisory board for Novo Nordisk, MSD, Bayer, Astellas, AbbVie, Sanofi and Boehringer Ingelheim, being a steering group member for Gilead, Astra Zeneca, Bayer and Novo Nordisk. All honorarium given to institution.